Table 1

Patients with ophthalmoplegia of undetermined cause

Patient NoAge (years )SexPattern of palsyAnti-GQlb IgG antibody titreSteroid treatmentPeriod for recoveryNeurological signsNeuroimaging study
124FR, VI<10+4 mR, proptosisCT, MRI
264ML, VI<10+3 mCT
356ML, VI<102 w
452FB, total<10+1 yCT, MRI
547MR, So<10+3 m
673FB, VI<102 mataxic gaitCT
740MB, VI<10+3 wCT, MRI
862FR, total20+3 mCT
951MR, VI<10+4 mCT, MRI
1045MR, total<10+4 mR, proptosisCT
1157ML, VI<10+6 mdecreased reflexCT
1269ML, So<104 mCT
1356FB, VI640+2 mareflexiaCT
1437MGPN<101 mCT, MRI
1540FL, So<10+4 mMRI
1661MR, total+L, VI<104 mCT
  • B = bilateral; VI = abducens palsy; total = total ophthalmoplegia; Sr = superior rectus muscle palsy; So = superior oblique muscle palsy; GPN = gaze paretic nystagmus; m = month(s), w = week(s), y = year(s); CT = head CT scan; MRI = magnetic resonance imaging.